Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohan de Silva

Showing results (81-90 of 109) with videos related to

Pageof 11
Sort By:
Neurobiology of Aging|July 18, 2021
A clinical, molecular genetics and pathological study of a FTDP-17 family with a heterozygous splicing variant c.823-10G>T at the intron 9/exon 10 of the MAPT geneDiana A Olszewska, Conor Fearon, Christopher McGuigan, et al.
Frontiers in Cellular Neuroscience|November 1, 2021
Extensive Anti-CoA Immunostaining in Alzheimer's Disease and Covalent Modification of Tau by a Key Cellular Metabolite Coenzyme ATammaryn Lashley, Maria-Armineh Tossounian, Neve Costello Heaven, et al.
Human Molecular Genetics|June 23, 2012
MAPT expression and splicing is differentially regulated by brain region: relation to genotype and implication for tauopathiesDaniah Trabzuni, Selina Wray, Jana Vandrovcova, et al.
Neurobiology of Aging|September 4, 2013
Validation of next-generation sequencing technologies in genetic diagnosis of dementiaJohn Beck, Alan Pittman, Gary Adamson, et al.
Journal of Neurochemistry|August 7, 2012
Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathiesConnie Luk, Yaroslau Compta, Nadia Magdalinou, et al.
Acta Neuropathologica Communications|February 6, 2020
Pre-clinical characterisation of E2814, a high-affinity antibody targeting the microtubule-binding repeat domain of tau for passive immunotherapy in Alzheimer's diseaseMalcolm Roberts, Ioanna Sevastou, Yoichi Imaizumi, et al.
Acta Neuropathologica|June 28, 2006
No alteration in tau exon 10 alternative splicing in tangle-bearing neurons of the Alzheimer's disease brainMartin Ingelsson, Karunya Ramasamy, Ippolita Cantuti-Castelvetri, et al.
Molecular Therapy. Nucleic Acids|August 7, 2018
Foamy Virus Vectors Transduce Visceral Organs and Hippocampal Structures following In Vivo Delivery to Neonatal MiceJohn R Counsell, Rajvinder Karda, Juan Antinao Diaz, et al.
Neurobiology of Disease|December 19, 2006
The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcriptsAmanda J Myers, Alan M Pittman, Alice S Zhao, et al.
Nature Genetics|August 15, 2006
Microdeletion encompassing MAPT at chromosome 17q21.3 is associated with developmental delay and learning disabilityCharles Shaw-Smith, Alan M Pittman, Lionel Willatt, et al.
Pageof 11

Showing results (81-90 of 109) with videos related to

Sort By:
Pageof 11
Neurobiology of Aging|July 18, 2021
A clinical, molecular genetics and pathological study of a FTDP-17 family with a heterozygous splicing variant c.823-10G>T at the intron 9/exon 10 of the MAPT geneDiana A Olszewska, Conor Fearon, Christopher McGuigan, et al.
Frontiers in Cellular Neuroscience|November 1, 2021
Extensive Anti-CoA Immunostaining in Alzheimer's Disease and Covalent Modification of Tau by a Key Cellular Metabolite Coenzyme ATammaryn Lashley, Maria-Armineh Tossounian, Neve Costello Heaven, et al.
Human Molecular Genetics|June 23, 2012
MAPT expression and splicing is differentially regulated by brain region: relation to genotype and implication for tauopathiesDaniah Trabzuni, Selina Wray, Jana Vandrovcova, et al.
Neurobiology of Aging|September 4, 2013
Validation of next-generation sequencing technologies in genetic diagnosis of dementiaJohn Beck, Alan Pittman, Gary Adamson, et al.
Journal of Neurochemistry|August 7, 2012
Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathiesConnie Luk, Yaroslau Compta, Nadia Magdalinou, et al.
Acta Neuropathologica Communications|February 6, 2020
Pre-clinical characterisation of E2814, a high-affinity antibody targeting the microtubule-binding repeat domain of tau for passive immunotherapy in Alzheimer's diseaseMalcolm Roberts, Ioanna Sevastou, Yoichi Imaizumi, et al.
Acta Neuropathologica|June 28, 2006
No alteration in tau exon 10 alternative splicing in tangle-bearing neurons of the Alzheimer's disease brainMartin Ingelsson, Karunya Ramasamy, Ippolita Cantuti-Castelvetri, et al.
Molecular Therapy. Nucleic Acids|August 7, 2018
Foamy Virus Vectors Transduce Visceral Organs and Hippocampal Structures following In Vivo Delivery to Neonatal MiceJohn R Counsell, Rajvinder Karda, Juan Antinao Diaz, et al.
Neurobiology of Disease|December 19, 2006
The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcriptsAmanda J Myers, Alan M Pittman, Alice S Zhao, et al.
Nature Genetics|August 15, 2006
Microdeletion encompassing MAPT at chromosome 17q21.3 is associated with developmental delay and learning disabilityCharles Shaw-Smith, Alan M Pittman, Lionel Willatt, et al.
Pageof 11